MedTrace Logo

Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

NCT07166354 · Status: NOT_YET_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-09-10

No results posted yet for this study

Summary

Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)

Conditions

  • Canities
  • Grey Hair

Interventions

DRUG

CS-002

CS-002 Topical Treatment

DRUG

Placebo Topical Solution

Placebo Topical Solution

Sponsors & Collaborators

  • Complex Science

    collaborator UNKNOWN

  • Applied Biology, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2027-06-15
Completion
2027-09-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07166354 on ClinicalTrials.gov